Triiodothyronine (T3) exerts several effects on thymus physiology. In this sense, T3 is known to stimulate thymic microenvironmental cells to enhance the production of extracellular matrix (ECM) moieties, which are relevant in thymocyte migration. Here, we further investigated the in vivo influence of T3 on ECM production, as well as on ECMârelated Tâcell migration events. For this, BALB/c mice were subjected to two protocols of T3 treatment: longâterm (30âdays) i.p. daily T3 injections or shortâterm (16âh) after a single T3 intrathymic injection. These two treatments did promote an enhancement in the expression of fibronectin and laminin, in both cortex and medullary regions of the thymic lobules. As revealed by the longâterm treatment, the expression of ECM protein receptors, including VLAâ4, VLAâ5 and VLAâ6, was also increased in thymocyte subsets issued from T3âtreated mice. We further used thymic nurse cells (TNC) as an in vitro system to study the ECMârelated migration of immature thymocytes in the context of thymic epithelial cells. Even a single intrathymic injection of T3 resulted in an increase in the ex vivo exit of thymocytes from TNC lymphoepithelial complexes. Accordingly, when we evaluated thymocyte migration in transwell chambers preâcoated with ECM proteins, we found an increase in the numbers of migrating cells, when thymocytes were derived from T3âtreated mice. Overall, our data show that in vivo intrathymic shortâterm i.p. longâterm T3 treatments are able to modulate thymocyte migration, probably via ECMâmediated interactions.